Novartis AG Common Stock (NVS)
Debt Repayment
$16.59B
TTM · Period ending: · USD
NVS Debt Repayment
Latest reported$16.59Bperiod ending
Latest reported$16.59Bperiod ending
NVS TTM Debt Repayment ($0.00 → $16.59B)
TTM debt repayment
High-resolution chart · PNG
NVS debt repayment history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Debt Repayment (USD) |
|---|---|
| 16,589,551,959 | |
| 14,617,022,180 | |
| 2,521,022,180 | |
| -959,000,000 | |
| 2,062,000,000 | |
| 2,773,000,000 | |
| 4,449,000,000 | |
| 5,228,999,999 | |
| 2,275,999,999 | |
| 609,999,999 | |
| 389,999,999 | |
| -1,556,000,000 | |
| -3,126,000,000 | |
| -2,021,000,000 | |
| -2,550,000,000 | |
| -4,323,999,999 | |
| -3,570,999,999 | |
| -6,272,999,999 | |
| -5,921,999,999 | |
| -3,907,000,000 | |
| 169,000,000 | |
| 295,000,000 | |
| 7,072,000,000 | |
| 6,942,000,000 | |
| 4,364,000,000 | |
| 5,740,000,000 | |
| -4,815,000,000 | |
| -3,177,000,000 | |
| -4,009,000,000 | |
| -4,063,000,000 | |
| 4,176,000,000 | |
| 3,005,000,000 | |
| 3,023,000,000 | |
| 2,727,000,000 | |
| 4,745,000,000 | |
| 5,027,000,000 | |
| 5,685,000,000 | |
| 5,324,000,000 | |
| 3,751,000,000 | |
| 6,518,000,000 | |
| 6,108,000,000 | |
| 5,710,000,000 | |
| 5,047,000,000 | |
| 3,849,000,000 | |
| 3,891,000,000 | |
| 5,126,000,000 | |
| 3,319,000,000 | |
| 727,000,000 | |
| 639,000,000 | |
| -530,000,000 | |
| -2,022,000,000 | |
| -1,698,000,000 | |
| -3,379,000,000 | |
| -2,946,000,000 | |
| -462,000,000 | |
| -2,800,000,000 | |
| -3,769,000,000 | |
| -6,336,000,000 | |
| -2,801,000,000 | |
| -3,331,000,000 | |
| 6,770,000,000 | |
| 11,763,000,000 | |
| 8,279,000,000 | |
| 11,987,000,000 | |
| 5,072,000,000 | |
| 6,068,000,000 | |
| 6,539,000,000 | |
| 3,065,000,000 | |
| 3,576,000,000 | |
| 1,633,000,000 | |
| -3,072,000,000 | |
| 673,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |